Heska Announces Increase in Odd-Lot Tender Offer Price to $9.50 per Share and Extension of Expiration Date

Heska Corporation

, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today that its Board of Directors has approved a $1.00 per share increase, from $8.50 to $9.50,  in the offer price for each share of its common stock held by stockholders who owned, of record or beneficially, 99 or fewer shares as of the close of business on August 21, 2012, and who continue to hold such shares through the expiration of the offer. This increased offer price reflects premiums of 18% and 5.3% over the last share sales price of the Company's common stock on the record date and September 21, 2012, respectively. The Company's Board of Directors has also approved an extension of the expiration date for this odd-lot tender offer from 5:00 p.m. Eastern time on October 2, 2012 to 5:00 p.m. Eastern time October 15, 2012.  Participants in the odd-lot tender offer are to receive the Company's recently announced dividend of $0.10 per share payable on October 10, 2012 regardless of whether the underlying shares have already been tendered or are tendered before or after the September 28, 2012 record date. In addition, the Company filed today with the Securities and Exchange Commission ("SEC") an amendment to the Company's Schedule TO on Schedule 13E-3.  This amendment was filed (1) to reflect a change in SEC filing form from Schedule TO to Schedule 13E-3 in response to a request of the SEC and (2) to reflect the increase in price per share offered by the Company and corresponding extension of the expiration date for the offer, as described above.  Notwithstanding this filing on Schedule 13E-3 rather than on Schedule TO, the Company and its board of directors have not changed their previously announced intentions for this offer and still currently intend for the Company to remain a public company for the foreseeable future, with its shares of common stock to remain listed on the Nasdaq Stock Market after the completion of the offer, regardless of whether the completion of the offer results in the Company having less than 300 stockholders of record. There can be no assurance given, however, that the board of directors will not determine at a later date to terminate the registration of the Company's common stock and its listing on the Nasdaq Stock Market if doing so is deemed by the board of directors at that time to be in the best interests of the Company and its stockholders.